Corvus Pharmaceuticals In... (CRVS)
NASDAQ: CRVS
· Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT
Corvus Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -9.72 | 3.77 | -7.55 | -2.19 | -6.48 | -3.87 | -3.18 | -2.98 | -4.18 | -1.2 | -0.61 | -0.64 | -1.39 | -2.3 | -3.04 | -4.98 | -2.4 | -2.3 |
PEG Ratio | 0.07 | -0.02 | 0.11 | -0.00 | 0.16 | 0.27 | -0.19 | 0.21 | 0.16 | 0.03 | -0.07 | -0.01 | n/a | 0.23 | 0.18 | 0.35 | 0.14 | 0.02 |
PS Ratio | n/a | n/a | 4.16K | n/a | n/a | n/a | 343.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.88 | 4.65 | 11.23 | 28.38 | 2.16 | 2.65 | 2.18 | 1.61 | 2.20 | 0.87 | 0.71 | 0.59 | 0.57 | 0.85 | 1.15 | 2.02 | 1.17 | 1.13 |
P/FCF Ratio | -52.82 | -27.64 | -43.2 | -55.72 | -20.15 | -17.13 | -16.36 | -13.16 | -20.82 | -5.2 | -5.24 | -5.3 | -7.52 | -11.88 | -16.35 | -25.25 | -8.92 | -12.1 |
P/OCF Ratio | -53.85 | -27.76 | -43.2 | -55.72 | -20.15 | -17.13 | -16.36 | -13.16 | -20.82 | -5.22 | -5.24 | -5.5 | -7.53 | -11.88 | -16.36 | -25.25 | -8.92 | -12.1 |
OCF/S Ratio | n/a | n/a | -96.19 | n/a | n/a | n/a | -21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 |
Quick Ratio | 8.91 | 4.90 | 1.54 | 0.92 | 3.62 | 0.00 | 4.07 | 4.44 | 4.73 | 4.99 | 3.55 | 3.62 | 5.67 | 6.86 | 5.65 | 6.79 | 5.39 | 4.91 |
Current Ratio | 8.91 | 4.90 | 1.54 | 0.92 | 3.62 | 3.40 | 4.07 | 4.53 | 4.82 | 4.90 | 3.49 | 3.67 | 5.80 | 6.95 | 5.65 | 6.97 | 5.59 | 4.94 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -16.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.22 | n/a | n/a | n/a | -851.25 | -822.45 | n/a | n/a |
Return on Equity | -0.1 | 0.31 | -0.37 | -3.24 | -0.08 | -0.17 | -0.17 | -0.14 | -0.13 | -0.18 | -0.29 | -0.23 | -0.1 | -0.09 | -0.1 | -0.1 | -0.12 | -0.12 |
Return on Assets | -0.09 | 0.26 | -0.18 | -0.68 | -0.07 | -0.14 | -0.15 | -0.12 | -0.11 | -0.15 | -0.24 | -0.18 | -0.09 | -0.08 | -0.08 | -0.09 | -0.11 | -0.11 |
Return on Invested Capital | -0.13 | -0.2 | -0.24 | -0.57 | -0.11 | -0.18 | -0.14 | -0.12 | -0.11 | -0.14 | -0.16 | -0.18 | -0.08 | -0.08 | -0.07 | -0.08 | -0.11 | -0.12 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -137.65 | n/a | n/a | n/a | -27.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -137.65 | n/a | n/a | n/a | -27.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -92.1 | n/a | n/a | n/a | -22.97 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -91.88 | n/a | n/a | n/a | -22.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |